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Serum response factor transcriptional activity is controlled
through interactions with regulatory cofactors such as the
coactivator MAL/MRTF-A (myocardin-related transcrip-
tion factor A). MAL is itself regulated in vivo by changes
in cellular actin dynamics, which alter its interaction with
G-actin. The G-actin-sensing mechanism of MAL/MRTF-A
resides in its N-terminal domain, which consists of three
tandem RPEL repeats. We describe the ﬁrst molecular
insights into RPEL function obtained from structures of
two independent RPEL
MAL peptide:G-actin complexes.
Both RPEL peptides bind to the G-actin hydrophobic cleft
and to subdomain 3. These RPEL
MAL:G-actin structures
explain the sequence conservation deﬁning the RPEL
motif, including the invariant arginine. Characterisation
of the RPEL
MAL:G-actin interaction by ﬂuorescence aniso-
tropy and cell reporter-based assays validates the signiﬁ-
cance of actin-binding residues for proper MAL
localisation and regulation in vivo. We identify important
differences in G-actin engagement between the two
RPEL
MAL structures. Comparison with other actin-binding
proteins reveals an unexpected similarity to the vitamin-D-
binding protein, extending the G-actin-binding protein
repertoire.
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Introduction
Actin is a major cytoskeletal constituent that can polymerise
to form helical actin ﬁlaments (F-actin), the organisation of
which contributes to cellular mechanical strength. Regulated
assembly, rearrangement and disassembly of F-actin are
critical in a wide variety of cellular processes, including cell
morphology, cell motility and cellular interactions required
for tissue formation and integrity (reviewed by Geiger and
Bershadsky, 2001; Revenu et al, 2004; Chhabra and Higgs,
2007). Actin also participates in non-cytoskeletal processes,
including transcription and chromatin remodelling, but here
its functional roles and the molecular interactions involved
are only poorly understood (Miralles and Visa, 2006; Chen
and Shen, 2007; Su et al, 2007). One such system is actin-
mediated control of the myocardin family transcriptional
coactivators MAL/MRTF-A (myocardin-related transcription
factor A) and MKL2/MRTF-B, which transduce Rho GTPase
signals to the transcription factor serum response factor
(SRF) (Cen et al, 2003; Miralles et al, 2003). Binding of
unpolymerised actin (G-actin) to the MRTF N terminus
inhibits MRTF activity by preventing their nuclear accumula-
tion and repressing transcriptional activation by the MRTF–
SRF complex (Miralles et al, 2003; Posern et al, 2004;
Vartiainen et al, 2007).
The MRTF regulatory domain contains three copies of the
RPEL motif (core sequence RPxxxEL; Pfam accession num-
ber: PF02755) (Finn et al, 2006), each of which functions as
an actin-binding element (Guettler et al, 2008). Mutations at
invariant positions within each RPEL motif impair interaction
with G-actin and de-repress the activity of the MRTF proteins
(Miralles et al, 2003; Vartiainen et al, 2007; Guettler et al,
2008). Similarly, myocardin, the constitutively nuclear and
active founding member of the myocardin family to which
the MRTFs belong (Wang et al, 2001), has a greatly reduced
afﬁnity for actin, reﬂecting sequence variations in its RPEL
motifs (Guettler et al, 2008). These observations have led to
the proposal that MRTF relocalisation and activation are
regulated directly by actin through RhoA-induced alterations
in the availability of G-actin (Miralles et al, 2003; Vartiainen
et al, 2007; Guettler et al, 2008). RPEL motifs also mediate
G-actin binding by members of the Phactr/Scapinin family of
phosphatase-1-binding proteins, but here their functional
signiﬁcance is unknown (Sagara et al, 2003; Allen et al,
2004).
The actin monomer comprises four subdomains: in the
actin ﬁlament, subdomains 1 and 3 are exposed at the barbed
end, whereas subdomains 2 and 4 are exposed at the pointed
actin ﬁlament end. F-actin assembly is regulated by actin
concentration, by ATP hydrolysis and by interactions
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3198between actin and regulatory proteins that control ﬁlament
nucleation, polymerisation, severing or maintenance of the
G-actin pool itself (reviewed by Pollard, 2007). A common
feature in many G-actin-binding proteins is an amphipathic
helix that engages a hydrophobic cleft separating actin sub-
domains 1 and 3, an interaction which is also likely to occur
between actin protomers in F-actin (Holmes et al, 1990;
Dominguez, 2004; Chereau et al, 2005).
The molecular basis for the RPEL
MAL:G-actin interaction,
and how this relates to sequence conservation within the
motif, were unknown. MAL:actin interaction interferes with
F-actin assembly (Posern et al, 2004). MAL:actin binding is
disrupted by proﬁlin, swinholide A, jasplakinolide, cytocha-
lasin D and tetramethylrhodamine actin modiﬁcation, but is
compatible with LatB and DNase I binding (Posern et al,
2004; SG, unpublished observations). Taken together
with previous structural studies of actin interactions
(Kabsch et al, 1990; Schutt et al, 1993; Morton et al, 2000;
Otterbein et al, 2001; Klenchin et al, 2005), these data
suggest that interaction between the RPEL motifs and
actin is likely to involve the subdomain 1–3 hydrophobic
cleft. However, the RPEL motif shares no obvious sequence
similarities with other cleft-binding domains such as the
WH2/verprolin domains (Dominguez, 2004). Here, we pre-
sent crystal structures of two RPEL peptides from MAL
individually bound to G-actin. Each RPEL peptide presents
two consecutive helices that bind actin in a similar manner to
two non-contiguous helices in the vitamin-D-binding
protein (DBP):G-actin complex. This observation draws at-
tention to four conserved positions shared by most G-actin
cleft-binding proteins. Structural and biophysical data com-
bined with cell-based reporter assays show that the sequence
conservation that deﬁnes the RPEL motif reﬂects its activity
as an actin-binding element crucial to the regulation of MAL
in vivo.
Results
For our structural analyses, we assembled puriﬁed skeletal
muscle G-actin bound to latrunculin B (LatB) and ATP with
individual 32-residue RPEL peptides from murine MAL.
These peptides corresponded to RPEL1
MAL, RPEL2
MAL and
RPEL3
MAL and are known to bind actin efﬁciently in vitro
(Guettler et al, 2008). High-resolution structures of the
RPEL1
MAL:LatB–actin:ATP and RPEL2
MAL:LatB–actin:ATP
complexes (hereafter shortened to RPEL
MAL:G-actin com-
plexes) were subsequently determined and reﬁned, but we
were unable to crystallise the RPEL3
MAL:G-actin complex
(Supplementary Table 1). When bound to actin, RPEL1
MAL
and RPEL2
MAL each contain two helices (a1 and a2) con-
nected by a short loop and end with a short C-terminal
capping (C-cap) region (Ermolenko et al, 2002) (Figure 1A).
The observed helical contents of RPEL1
MAL and RPEL2
MAL
are consistent with secondary structure predictions (56, 65
and 47%, respectively, for each of the three MAL RPEL
peptides). However, circular dichroism (CD) experiments
revealed that each RPEL peptide is largely unstructured in
solution (a-helical content of 5.2, 4 and 4.3%, respectively)
(Supplementary Figure S1), indicating that the observed
RPEL peptide secondary structure is induced on binding
actin.
Structure of the RPEL2
MAL:G-actin complex
We ﬁrst describe the higher resolution RPEL2
MAL:G-actin
structure as it has a canonical RPEL sequence as deﬁned in
the Pfam database (Figure 1A). RPEL2
MAL wraps around
actin, making intimate contacts with the subdomain 1–3
hydrophobic cleft and a ledge on subdomain 3 (Figure 1B).
A total surface area of 1070A
2 is buried within the interface,
accounting for almost 30% of the RPEL2 surface area and
60% of RPEL2 residues. Helix a1
RPEL2 (residues 115–123)
binds within the actin hydrophobic cleft in a similar manner
to WH2-containing proteins that engage this region
(Figure 1B; Dominguez, 2004). a1
RPEL2 runs from front to
back in the standard view of actin (Figure 1B), making
hydrophobic contacts through residues L118, I122 and the
aliphatic portion of K121 to the base of the actin subdomain
1–3 hydrophobic cleft (Figure 1C). The Ne of K121 adopts two
conformations, one hydrogen bonding with the G146
actin
main chain carbonyl oxygen and the other forming a salt
bridge with the side chain of E167
actin.
The invariant arginine, R125 in RPEL2
MAL, is located
within the short loop (deﬁned hereafter as the R-loop) con-
necting the helices a1
RPEL2 and a2
RPEL2 (Figures 1B and 2A).
The R125 side chain, which is critical for actin interaction
(Guettler et al, 2008), forms a cation–p interaction with the
Y169
actin side chain through its guanidino group, as well as a
side chain hydrogen bond with the main chain carbonyl
oxygen of E167
actin (Figure 1C). Furthermore, R125 makes a
salt bridge with the C-terminal carboxylate of F375
actin, the C-
terminal residue of actin. The four residues within the R-loop
have an extended conformation. The conserved proline,
P126, constrains the R-loop backbone and stabilises the
acute angle between a1
RPEL2 and a2
RPEL2. Its carbonyl oxy-
gen, together with the R128 main chain nitrogen, hydrogen
bond with the Y169
actin hydroxyl moiety (Figure 1C).
Y169
actin therefore has a central and crucial function to
RPEL2 interaction having its side chain anchored through
R-loop hydrogen bonds and pincered between the R125 side
chain and those from R128/L131 (see below) (Figure 2B, right
panel).
Helix a2
RPEL2 (residues 128–134) and its C-cap residues
135–137 contact a ‘ledge’ on actin subdomain 3 centred on
Y166
actin. The only other actin-binding protein shown to
engage this region of actin in a similar manner is the
structurally unrelated DBP (Otterbein et al, 2002; Verboven
et al, 2003) (see Discussion section). Contacts with the
subdomain 3 ledge are predominantly hydrophobic involving
RPEL2 side chains L131, I136 and L137 (Figure 1C;
Supplementary Figure S2B, right panel). Overall, the
RPEL2
MAL:G-actin structure reveals that the majority of
RPEL motif sequence conservation occurs at positions that
mediate direct interactions with actin (Figure 2A) or intra-
RPEL molecular interactions within the actin complex. The
RPEL motif thus reﬂects the preservation of a functional G-
actin-binding element.
Distinct differences in RPEL1
MAL and RPEL2
MAL R-loop
actin contacts
The RPEL1
MAL:G-actin structure shares many of the interac-
tions seen in the RPEL2
MAL:G-actin complex. These are made
by structurally equivalent hydrophobic residues in helix a1
(residues 72–79), helix a2 (residues 84–92) and the C-cap
(Supplementary Figure S2A and B). The RPEL1
MAL interac-
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MAL
(811A ˚ 2) despite the higher afﬁnity (see below). Core contacts
from the R-loop R81 side chain and R84 main chain, which
stack either side of Y169, are preserved (Figure 2B). However,
there are signiﬁcant differences in the way R-loop
RPEL1 con-
tacts actin, mainly reﬂecting its non-canonical RRxxxEL core
sequence (Figure 1A). The R-loop
RPEL1 follows a trajectory
distinct from R-loop
RPEL2 with an r.m.s. difference of 2.9A ˚
over 12 C-alpha atoms (calculated by superposing only their
respective actin partners), indicating a degree of structural
plasticity (Figure 2C). This difference most likely reﬂects the
substitution of the canonical RPEL proline by R82, which
makes RPEL1-speciﬁc actin contacts, speciﬁcally a salt bridge
with E167
actin and a hydrogen bond with the phenolic oxygen
of Y166
actin (Figure 2C; Supplementary Figure S2A). These
contacts draw the RPEL1
MAL peptide away from Y169
actin
such that the C-alpha atom of invariant R81
RPEL1 is 3.0A ˚ from
the equivalent R125 of RPEL2 (Figure 2B and C). R-loop main
chain hydrogen bond distances to the Y169
actin side chain are
therefore much longer in RPEL1
MAL. Strikingly, R81 is unable
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Figure 1 Structure of an RPEL peptide bound to G-actin. (A) Sequence alignment of individual RPEL motifs from murine MAL, myocardin
(transcript variant A) and Phactr1. RPEL2
MAL secondary structure and features discussed in text are shown above the sequence. Selected
conserved residues are highlighted. (B) Two views of the RPEL2
MAL:G-actin complex, related by a 901 rotation around the horizontal axis.
Right-hand panel is the classical view of the ‘front’ surface of actin (white with subdomains labelled 1–4). RPEL2
MAL is drawn in green
(cartoon) with highly conserved RPEL residues that interact with actin shown as sticks. The hydrophobic cleft and the subdomain 3 ledge of
actin are indicated by red dashed circles. (C) Stereo view of the RPEL2
MAL (green cartoon) interaction with G-actin. Actin surface is drawn as
per (B) with selected RPEL-interacting residues shown as grey sticks and key hydrogen bonds are indicated as dashed lines. Two glycerol
molecules, used as a cryoprotectant, are shown in yellow.
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Figure 2 The RPEL1
MAL and RPEL2
MAL R-loops make different contacts with G-actin. (A) Summary of RPEL1/RPEL2 interactions with G-actin mapped
onto a HMM (Hidden Markov Model) representation for the RPEL motif (Schuster-Bockler et al, 2004). Helices a1a n da2 are highlighted in pink and
conserved residues from the RPEL HMM are highlighted in yellow. Boxes with solid lines indicate RPEL
MAL side chain-mediated interactions with actin,
whereas those with dashed lines describe RPEL
MAL main chain-mediated interactions. Interactions that are conserved between RPEL peptides 1 and 2
are shown in black text and RPEL1- and RPEL2-speciﬁc ones in blue and green, respectively. (B) Close-up view of RPEL1
MAL and RPEL2
MAL interactions
close to Y169
actin.L e f tp a n e l ,R P E L 1
MAL:G-actin; right panel, RPEL2
MAL:G-actin. A 2mFo DFc electron density map calculated around each RPEL is
shown in blue contoured at 1s. Note that F375 is disordered in the RPEL1:actin complex. (C) Comparison of RPEL1
MAL (cyan) and RPEL2
MAL (green)
motifs following superposition of their respective actin subunits. Important RPEL and G-actin residues described in the text are highlighted. Selected
actin residues are shown in dark blue (contacting RPEL1) and dark green (contacting RPEL2), respectively. (D)L o s so fF 3 7 5o fb-actin affects binding of
MAL RPEL motifs differentially. NIH3T3 ﬁbroblasts transiently expressing either wild-type FLAG–b-actin (W) or FLAG–b-actin-DF375 (D)l a c k i n gt h e
C-terminal residue were lysed and extracts were probed with bacterially produced GSTor GST–RPEL peptide fusions as indicated. NIH3T3 cell lysates
(input) and bound material were subjected to SDS–PAGE and western blotting for detection of the FLAG tag (WB: anti-FLAG) or endogenous b-actin
(WB: anti-b-actin). Ponceau stain of the membrane indicates the levels of GST fusion proteins.
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ylate of F375
actin, which is instead disordered (Figure 2B;
Supplementary Figure S2A). To the best of our knowledge,
only the twinﬁlin C-terminal domain has been shown earlier
to make contact with the carboxylate of F375
G-actin
(Paavilainen et al, 2008).
To validate these apparent differences in how RPEL1
MAL
and RPEL2
MAL engage actin, we tested whether complex
formation by RPEL1
MAL and RPEL2
MAL is differentially sensi-
tive to deletion of F375
actin using GST–RPEL pull-down
assays (Guettler et al, 2008). RPEL1
MAL and RPEL2
MAL re-
covered exogenous wild-type b-actin and endogenous b-actin
efﬁciently from total cell lysates, but only the RPEL2
MAL:
G-actin interaction was sensitive to deletion of F375
actin,i n
agreement with our structural data (Figure 2D). RPEL3
MAL
was also sensitive to the F375
actin deletion, despite its much
lower apparent afﬁnity for G-actin (Figure 2D), and would
thus be predicted to bind in a similar manner to RPEL2
MAL.
Fluorescence anisotropy validation of MAL RPEL:G-actin
interaction
To conﬁrm the structural features of each RPEL
MAL:G-actin
interaction, we performed ﬂuorescence anisotropy assays
using N-terminally FITC-conjugated RPEL peptides analogous
to those used for the structural studies. Peptides were in-
cubated with LatB-bound G-actin (peptide 0.5mM; LatB–actin
0–59mM) and the actin-binding afﬁnity was calculated from
anisotropy by nonlinear regression. The results are shown in
Figure 3A. We also included an analysis of MAL RPEL3, for
which no structural data are available. The wild-type peptides
corresponding to RPEL1 and 2 bound relatively tightly, with
apparent dissociation constants (Kd) of 1.0±0.3 and
1.9±0.1mM, respectively, whereas the RPEL3 peptide
bound weakly (Kd of 28.9±1.1mM). These afﬁnities differ
slightly from those determined earlier as discussed in the
Materials and methods section, but are generally comparable
(Guettler et al, 2008).
Loss-of-contact alanine substitutions of both helix a1
hydrophobic residues (a1
AA mutations), which contact the
hydrophobic cleft of actin, virtually abolished detectable
interaction with actin for all three RPEL peptides
(Figure 3A). A similar result was observed when loss-of-
contact alanine substitutions were introduced at hydrophobic
residues within helix a2 and its C-cap sequence
(a2
AAA mutations). This region makes hydrophobic contacts
with the subdomain 3 ledge. a2
AAA mutations within
RPEL1
MAL greatly reduced binding but nonetheless binding
was still detectable (Kd¼24.0±1.5mM) (Figure 3A).
Combination of both a1
AA and a2
AAA mutations eliminated
measurable actin binding of all three RPEL peptides (data not
shown). Mutations at the conserved RPEL arginine and pro-
line residues had context-speciﬁc effects, consistent with the
distinct molecular interactions revealed in the structures.
Mutation of the invariant RPEL arginine residue (RPEL1,
R81; RPEL2, R125; RPEL3, R169) abolished measurable
actin binding for RPEL2 and 3, but only reduced RPEL1
binding (Kd¼17.7±2.4mM). The relatively small effect of
the RPEL1 R81A mutation may reﬂect its failure to engage the
F375
actin carboxylate, whereas the RPEL1
MAL-speciﬁc
ionic interaction between R82 and E167
actin provides a com-
pensatory effect. Consistent with this, mutation of both R81
and R82 of RPEL1
MAL to alanine effectively reduced the
RPEL1-actin afﬁnity (Kd¼44.5±3.5mM), whereas the
charge-reversal mutation RR81/82DD rendered binding un-
detectable.
The effect of alanine substitution of the conserved
RPEL proline residue was also context-dependent. The
RPEL2
MAL P126A mutant reduced afﬁnity by 16-fold
(Kd¼30.8±2.3mM), consistent with an important role for
the proline in maintaining the R-loop conformational integ-
rity. In contrast, the analogous alanine substitution in
RPEL1
MAL, which contains an arginine at this position,
reduced afﬁnity only 3.5-fold (Kd¼3.7±0.5mM), whereas
conversely, replacement of RPEL2
MAL P126 with arginine
(analogous to RPEL1
MAL), also reduced binding afﬁnity
(Kd¼19.5±3.1mM). The different contacts seen in the two
structures are thus reﬂected in contrasting roles for the
conserved RPEL R and P residues in RPEL1
MAL and
RPEL2
MAL, respectively (see Discussion). Residues I122 and
P126 of RPEL2
MAL are substituted by G and S, respectively, in
the RPEL2 motif of myocardin (Figure 1A). These substitu-
tions eliminate crucial G-actin contacts and are likely to
account for the weak actin afﬁnity exhibited by myocardin
(Guettler et al, 2008). Alanine substitution at the conserved
RPEL glutamate, which does not make direct contact with
actin, had only a small effect on RPEL1
MAL:G-actin binding
afﬁnity (E86A, Kd¼2.7±0.4mM), and did not affect
RPEL2
MAL:G-actin interaction (E130A, Kd¼1.9±0.2mM).
The conservation of this residue among the family of RPEL
motifs may reﬂect an additional conserved role unrelated to
actin binding (see Discussion).
RPEL3
MAL retains all the equivalent residues to RPEL2
MAL
that make direct interaction with actin, yet its afﬁnity for
actin is an order of magnitude lower than that of either
RPEL1
MAL or RPEL2
MAL (Guettler et al, 2008). We hypothe-
sised that non-consensus residues might be impairing RPEL3
binding to actin. Mapping the MAL RPEL3 sequence onto the
RPEL1/RPEL2 structures identiﬁed that G171 immediately
before helix a2
RPEL3 could introduce considerable ﬂexibility
into the R-loop. More importantly, a proline residue at posi-
tion 172 has no main chain amide available to hydrogen bond
to the Y169
actin hydroxyl group. To test this hypothesis, we
generated an ‘RPEL2-like’ RPEL3
MAL peptide by replacing
RPEL3 G171/P172 by the corresponding residues from
RPEL2
MAL, E and R. This substitution improved actin-binding
afﬁnity almost six-fold, to 4.8±0.1mM, compared with the
wild-type RPEL3
MAL peptide, with actin binding remaining
dependent on hydrophobic contacts between a2
RPEL3 and the
subdomain 3 ledge contact (Figure 3A).
Integrity of RPEL:G-actin contacts is required for MAL
regulation
We observed earlier that mutations of the conserved core
arginines, which lower RPEL
MAL:G-actin afﬁnity, result in
partial or complete nuclear accumulation of MAL protein in
serum-starved cells, potentiate its transcriptional activity and
uncouple its activation from Rho signalling (Guettler et al,
2008). We therefore tested whether the structure-based muta-
tions that disrupt actin binding have a similar effect on MAL
function in vivo. The loss-of-hydrophobic-contact mutations
in helix a1, helix a2 and the ﬂanking C-cap (a1
AA and a2
AAA)
were introduced into full-length MAL (Figure 3B), and the
mutant proteins were expressed by transient transfection in
NIH3T3 cells. Activity was monitored by assessment of the
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ability to activate a co-transfected reporter gene for their
transcription factor target SRF (Figure 3C and D).
Alanine substitutions at each core RPEL arginine substan-
tially increased MAL nuclear localisation and SRF reporter
activity, with mutations in RPEL1
MAL having a lesser effect
than those in the other motifs, as reported previously
(Guettler et al, 2008). Similar results were obtained on
introduction of the a1
AA and a2
AAA substitutions into indivi-
dual RPEL motifs. The a1
AA and a2
AAA mutant derivatives of
MAL all activated the SRF reporter more strongly than wild-
type MAL. Mutations in RPEL1
MAL were again less effective
than those in the other RPEL motifs, although the RPEL1
MAL
a1
AA and a2
AAA mutants were somewhat more active than
the RPEL1
MAL R81A (x23) mutant. All the mutants exhibited
a decreased dependence on functional Rho, with the com-
bined introduction of the a1
AA mutation into all three repeats
having the largest effect. Consistent with their increased
activity in the reporter assay, each mutant exhibited substan-
tially increased nuclear localisation. Taken together with the
ﬂuorescence anisotropy data, these results support the view
that binding of actin to MAL is required to maintain its
cytoplasmic localisation and suppress its activity as a tran-
scriptional coactivator.
Discussion
Implications for RPEL
MAL:G-actin interactions and
regulation of myocardin family SRF coactivators
Here, we describe in atomic detail how G-actin binds indivi-
dual RPEL peptides from the MAL N-terminal regulatory
domain and the structural fold adopted by an RPEL motif.
The structures demonstrate that virtually all sequence con-
servation of the RPEL motif reﬂects its function as an actin-
binding element. Structure-directed functional studies show
that authentic MAL regulation requires that each of the three
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Figure 3 In vitro and in vivo validation of the RPEL1
MAL and RPEL2
MAL structures. (A) Fluorescence anisotropy assay for characterisation of
the RPEL
MAL:G-actin interaction. Anisotropies of FITC-conjugated 32 amino-acid RPEL peptides at a concentration of 0.5mM were measured
over a range of LatB–actin concentrations. Anisotropy values were normalised by subtracting the anisotropy obtained in the absence of LatB–
actin from all anisotropies for each peptide and multiplied by 1000. Graphs correspond to one of three experiments done in duplicate.
Dissociation constants (Kd) for RPEL
MAL:G-actin interactions were calculated by nonlinear regression from each duplicate after normalisation
using GraFit software (see Materials and methods). Kd values shown are means from three independent experiments with s.e.m. (B) Schematic
representation of N-terminal MAL mutations used for luciferase reporter assays and immunoﬂuorescence. The mutated region is shown in red.
(C) SRF reporter activation by structure-derived MAL point mutants. The indicated MAL derivatives were expressed with and without C3
transferase coexpression in serum-starved NIH3T3 cells. Reporter activation was normalised to reporter activation conferred by SRF-VP16 or
SRF-VP16 plus C3 transferase. x23, 1x3, 12x and xxx refer to MAL derivatives described earlier (Guettler et al, 2008): x23, R81A; 1x3, R125A;
12x, R169A; xxx, R81A R125A R169A. Data from three independent experiments are shown. Error bars, s.e.m. (D) Subcellular localisation of
structure-derived MAL point mutants. The localisation of the indicated constructs was scored as predominantly nuclear (nuc), comparable
intensity in nucleus and cytoplasm (nuc/cyt) or predominantly cytoplasmic (cyt) in 100 serum-starved cells. Mutants are described in (B, C).
Data from three independent experiments are shown. Error bars, s.e.m.
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tent to bind G-actin. Together with our previous demonstra-
tion that signalling induces changes in MAL-actin interaction
in vivo (Vartiainen et al, 2007), our data are consistent with a
model in which alterations to actin loading onto the regula-
tory domain control MAL nuclear accumulation.
Actin binding is required for Crm1-dependent MAL nuclear
export (Vartiainen et al, 2007) and is also likely to inhibit
activity of a putative nuclear import signal within the RPEL2–
RPEL3 linker (Vartiainen et al, 2007; Guettler et al, 2008). It is
thus likely that different actin-bound states of the regulatory
domain will exhibit different interactions with import and
export factors. We identiﬁed earlier a stable 3:1 actin–MAL
complex in gel ﬁltration experiments (Vartiainen et al, 2007).
This complex can effectively sequester actin from polymer-
isation, so the arrangement of the actin molecules in it must
differ from that occurring within the actin ﬁlament (Posern
et al, 2004). The relevance of this complex to MAL regulation,
in terms of its competence to bind import factors or to recruit
Crm1, remains unclear. Although the existence of the 3:1
actin–MAL complex is consistent with each RPEL engaging
one actin molecule in the manner described in this study, this
awaits direct conﬁrmation. Our current work is focused on
elucidation of the structure of the 3:1 actin–MAL complex.
Several considerations suggest that in the context of the
MAL N-terminal regulatory domain the RPEL motifs do not
function independently in a ‘beads-on-a-string’ manner. First,
the high apparent afﬁnity of the intact regulatory domain for
actin compared with individual RPEL peptides suggests that
cooperative actin–actin interactions may facilitate complex
formation. Second, the non-canonical RPEL1 motif, and its
distinct mode of actin binding, has been selected throughout
metazoan evolution, as have the sequences responsible for
the low afﬁnity of the RPEL3 motif, suggesting the motifs
have distinct functional roles. Third, comparative studies of
MAL and its constitutively nuclear relative myocardin
suggest that actin-regulated nuclear accumulation appears
determined by the RPEL1–RPEL2 unit, RPEL3 being inter-
changeable (Vartiainen et al, 2007; Guettler et al, 2008).
It will be interesting to examine whether RPEL3 loads actin
last in an ordered assembly of multiple actin molecules onto
the triple RPEL repeat region of MAL, and the potential
functional signiﬁcance of this for MAL cytoplasmic–nuclear
shuttling.
In addition to controlling nuclear accumulation of MAL,
actin binding also appears to repress the ability of nuclear
MAL to activate transcription through SRF (Vartiainen et al,
2007; Guettler et al, 2008). At this level, MAL-bound actin
may modulate the formation of ternary complexes of MAL,
SRF and DNA, recruit transcriptional repressors or interfere
with the formation of active transcription complexes.
The RPEL motif binds G-actin similarly to DBP
To understand how MAL is able to compete with other actin-
binding proteins, including the highly abundant G-actin-
buffering proteins proﬁlin and thymosin b4 (Pollard and
Borisy, 2003), we compared our RPEL peptide:G-actin struc-
tures with other actin-binding protein structures. This analy-
sis showed that ‘cleft-and-ledge’ contacts from RPEL1 and 2
are strikingly similar to those made by vitamin D-binding
protein (DBP), a large multi-domain actin-sequestering pro-
tein quite unrelated to the RPEL motif (Otterbein et al, 2002;
Verboven et al, 2003) (Figure 4A). DBP uses two helices,
structurally equivalent to those of RPEL1/2, to engage both
the actin subdomain 1–3 hydrophobic cleft and the subdo-
main 3 ledge of actin (Figure 4A). This region of DBP and
RPEL2
MAL superposes with an r.m.s. difference of 1.5A ˚ over
17 C-alpha atoms. The DBP helices are non-contiguous,
however, being separated by over 100 amino acids in the
primary sequence, and DBP therefore has no equivalent of
the RPEL R-loop (Figure 4A). At least ﬁve structurally
equivalent residues are shared by the RPEL motif and DBP.
These include L184
DBP and L188
DBP (from helix a1); K191
DBP,
which hydrogen bonds to E167
actin main chain (equivalent to
R81/R125 of RPEL1/2); V294
DBP and F298
DBP, which contact
the subdomain 3 ledge (Figure 4A, DBP residue numbers are
taken from 1MA9 coordinates). The latter residue resides
within a lengthened helix, which replaces the C-cap attached
to the a2
RPEL, but has an analogous function to a2
RPEL C-cap
residues I92/I136, which contact the subdomain 3 ledge. The
unexpected similarity of actin contacts between RPEL and
DBP raises the possibility that other cleft-and-ledge actin-
binding proteins may yet be found.
An extended family of G-actin cleft-binding proteins
Similar to DBP and gelsolin, RPEL1 and RPEL2 of the MRTFs
contain a helix that binds in the forward direction of the
hydrophobic cleft in actin, a frequently used site for actin-
binding proteins (McLaughlin et al, 1993; Robinson et al,
1999; Otterbein et al, 2002; Verboven et al, 2003; Burtnick
et al, 2004; Paavilainen et al, 2008) (Figure 4B and C).
‘Forward’ is deﬁned as the peptide ligand (N-C) running
front-to-back in the conventional actin view (Dominguez,
2004) (Figure 1B). The unexpected similarity between RPEL
and DBP actin contacts close to the subdomain 3 ledge
(Figure 4A) prompted us to perform structure-based
sequence alignments with other actin cleft-binding proteins
to examine common structural features. Previous analysis
identiﬁed three hydrophobic residues (designated A, B and C
herein) that are present in most actin cleft-binding proteins
(Dominguez, 2004) (Figures 4C and 5). Inclusion of RPEL and
DBP contacts with actin identiﬁed an additional, highly
conserved interaction involving a basic residue (designated
D; see Figure 5), which was not explicitly described earlier as
being conserved in both forward and reverse orientations.
Residues A and D are present independently of the orienta-
tion of the cleft-binding helix, and they superpose well
between the different structures (Figure 4C). There is more
variability in the interactions made by residues B and C: for
example, the hydrophobic residue C in the RPEL
MAL a1 and
DBP helices is oriented towards the cleft ﬂoor rather than the
side of the cleft. This positions residue B, which is in some
instances a lysine residue, outside the cleft on the subdomain
3 surface but still able to contribute hydrophobic contacts via
the aliphatic portion of its side chain (Figure 4C; see
Supplementary Figure S2A).
In summary, our structural analysis provides the
ﬁrst detailed picture of how an RPEL peptide binds to
G-actin and suggests functionally important differences
between each MAL RPEL motif. To understand how
MAL is regulated by higher order RPEL:G-actin
assemblies, future experiments will concentrate on
G-actin complexes with an intact triple RPEL domain
from MAL.
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Plasmids
Sequences encoding mouse MAL RPEL peptides (see GST pull-
down assays) were inserted into a vector derived from pET-41a(þ)
(Novagen; described in Vartiainen et al, 2007) for bacterial
expression of GST–(His)6–S-tag fusions (Guettler et al, 2008).
Mammalian expression constructs for wild-type mouse MAL(ﬂ)-
HA2 and human FLAG-b-actin and their mutant derivatives were
based on pEF (Sotiropoulos et al, 1999; Miralles et al, 2003). SRF-
VP16, C3 transferase and luciferase reporter plasmids were
described earlier (Sotiropoulos et al, 1999; Geneste et al, 2002).
Proteins and peptides
Actin was prepared from rabbit skeletal muscle as described earlier
(Feuer et al, 1948; Spudich and Watt, 1971). Peptides (both
A
B
C
D
L118
I122
R125
L184
L118
L188
I122
K191
R125
V294
L131
F298
I136
MIM
WIP 
WASP 
WAVE2 
Ciboulot
RPEL2
Gelsolin
N
C
DBP
DBP
RPEL2
Front
Back
A
B
C
D
 
Forward (F)
Reverse (R)
N
CN
C
MIM (R)
WIP (R)
WASP (R)
WAVE2 (R)
Ciboulot (R)
RPEL2 (F)
RPEL1 (F)
Gelsolin (F)
DBP (F)
Actin-
binding
  helix
Figure 4 Structural comparison with known G-actin-binding proteins. (A) Left: the DBP:G-actin complex structure (PDB code 1MA9, actin as a
white surface, DBP as grey cartoon ribbon). DBP helices that interact with the actin hydrophobic cleft and subdomain 3 ledge are shown
in orange. Right: close-up of the actin hydrophobic cleft showing the binding interface of DBP and RPEL2
MAL superposed onto their respective
G-actin partners. RPEL2
MAL is shown in green. DBP residue numbering is taken from the 1MA9 coordinates. (B) Left: bottom view of
superposed WH2 motif containing proteins together with RPEL2
MAL bound to G-actin. MIM, black (PDB code 2D1K); WIP, marine blue (2A41);
WASP, yellow (2A3Z); WAVE2, pink (2A40); Ciboulot, red (1SQK); RPEL2
MAL (green) gelsolin, purple (1EQY). Right: close up of the left-hand
panel showing the side chains at the four conserved positions (A–D) together with an electrostatic surface of actin (red indicating acidic
regions). The RPEL2
MAL a1 helix and its residue numbers are shown in green. (C) Structural alignment of helices equivalent to RPEL helix a1
from various G-actin-binding proteins. The four equivalent key residues common to these actin-binding proteins are displayed as sticks. The
orientation of each helix is indicated in parentheses; R, reverse and F, forward.
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three RPEL motifs of MAL were synthesised and HPLC-puriﬁed by
the Cancer Research UK Protein and Peptide Chemistry Laboratory
(RPEL1
MAL: MAL67–98; RPEL2
MAL: MAL111–142 and RPEL3
MAL:
MAL155–186). During the course of these studies, we discovered
that the RPEL peptides exhibit varying degrees of methionine
oxidation on storage and therefore we subjected all peptides to
reduction and re-puriﬁcation before analysis. Absorption of
unlabelled peptides was measured at 215nm (peptide bond) in an
Agilent 8453 UV/Vis spectrophotometer and concentrations were
calculated using e215 ¼1000M
 1cm
 1 per peptide bond. Absorption
of FITC-conjugated peptides was measured at 492nm (FITC)
in a NanoDrop spectrophotometer (NanoTechnologies) using
e492¼83000M
 1cm
 1.
Preparation of LatB–actin
We used LatB to block actin polymerisation, as successfully used in
earlier crystallographic studies of actin (Morton et al, 2000; Hertzog
et al, 2004). Brieﬂy, rabbit skeletal muscle actin was dialysed into
Mg
2þ–G-buffer (2mM Tris–HCl pH 8.0, 0.3mM MgCl2, 0.2mM
EGTA, 0.2mM ATP and 0.5mM DTT) and co-incubated overnight at
41C with a 10-fold molar excess of LatB (Calbiochem), added from a
50mM stock in DMSO. Un-complexed actin was polymerised for 1h
at 41C on addition of 20  initiation buffer (2M NaCl, 60mM MgCl2
and 10mM ATP). Actin ﬁlaments and insoluble material were
removed by ultracentrifugation at 200000g for 15min at 41C. For
crystallisation complex preparation, LatB–actin was concentrated
using a 5000 MWCO Vivaspin 500 concentrator with a PES
membrane, followed by another round of ultracentrifugation.
CD measurements and spectra deconvolution
CD spectra were recorded using an Aviv 202SF spectrophotometer
in a 0.2mm path length cell at 201C. Data were recorded every
0.2nm with a data acquisition time of 3s in the range of 188–
260nm. Each peptide was dissolved in 10mM Tris pH 8, 10mM
NaCl to a ﬁnal concentration of 250mM. Each spectrum was the
average of three repeated scans. The composition of the secondary
structure of each peptide was analysed from CD spectra using the
DICHROWEB server (Whitmore and Wallace, 2004) and the algorithm
CONTIN (van Stokkum et al, 1990).
Crystallisation, data collection and structure determination
RPEL:LatB–G-actin:ATP complexes were prepared at a molar ratio of
3:1 of RPEL:LatB-actin and at a ﬁnal actin concentration of 12mg/ml.
The complexes were crystallised at 201C using the sitting drop
vapour diffusion method. Sitting drops of 1ml consisted of a 1:1
(volume:volume) mixture of protein and a well solution containing
0.15M potassium thiocyanate, 0.1M sodium cacodylate pH 6.5,
15% polyethylene glycol 6000 for the RPEL1:LatB–actin complex,
and 0.2M sodium chloride, MES pH 6 and 20.5% polyethylene
glycol 6000 for the RPEL2:LatB–actin complex. Crystals were ﬂash-
frozen in liquid nitrogen with 20% glycerol as a cryoprotectant.
X-ray datasets were collected at 100K at the ID14-2 beamline of
European Synchrotron Radiation Facility (Grenoble, France) for
RPEL1 and at I03 beamline of Diamond Light Source (Oxford, UK).
RPEL1:LatB–actin and RPEL2:LatB–actin structures were solved
and reﬁned at 2.35 and 1.45A ˚, respectively. Data collection and
reﬁnement statistics are summarised in Supplementary Table 1.
Both datasets were indexed with MOSFLM and scaled and merged
with SCALA (CCP4 (Collaborative Computational Project N), 1994).
Molecular replacement for each complex used a G-actin:Latrunculin
A (Bubb et al, 2002) (PDB code: 1IJJ) search model in PHASER
(McCoy et al, 2005). Reﬁnement was carried out using REFMAC5
(Murshudov et al, 1997). Model building was performed with COOT
(Emsley and Cowtan, 2004). The ﬁnal 2mFo DFc electron density
map covering RPEL1 and RPEL2 peptides shows unambiguous
density for residues 72–98 and 111–141, respectively. Model
validation used PROCHECK (Laskowski et al, 1993) and ﬁgures
were prepared using the graphics program PYMOL
(http://www.pymol.org). Coordinates have been deposited within
the PDB with codes 2V51 (RPEL1
MAL:G-actin) and 2V52
(RPEL2
MAL:G-actin).
Fluorescence anisotropy
Fluorescence anisotropy assays were performed essentially as
described (Guettler et al, 2008). Binding experiments were carried
out in 50ml volumes in Mg
2þ–F-buffer (2mM Tris–HCl pH 8.0,
100mM NaCl, 3mM MgCl2, 0.2mM EGTA, 0.7mM ATP and 2mM
DTT). FITC-conjugated peptides were used at 0.5mM, whereas
LatB–actin was added from 1nM up to 59mM. Plates were read in a
Saﬁre
2 microplate reader (Tecan) after 2h co-incubation at room
temperature to achieve binding equilibrium. The Saﬁre
2 was used
in ﬂuorescence polarisation mode (excitation, 470±20nm;
emission, 525±20nm; 10 reads; integration time, 40ms) with the
manufacturer’s ‘Magellan’ software (version 5.03). Anisotropy (A)
was calculated using the formula A¼(Iparallel Iperpendicular)/
(Iparallelþ2Iperpendicular), where Iparallel and Iperpendicular denote the
ﬂuorescence intensities parallel and perpendicular to the excitation
Binding orientation: forward
Protein PDB AB CD
MAL RPEL1 2V51 68 SERKNVLQLKLQQRRTREELVSQGIMPPLKS    98
MAL RPEL2 2V52       112 ARTEDYLKRKIRSRPERAELVRMHILEETSA   142
DBP            1MA9       178 SPTVCFLKERLQLKH/ /VCT-YFMPAAQL 304
Gelsolin       1EQY 73 ESGAAAIFTVQLDDY 87
Actin cleft Actin ledge
helix
Binding orientation: reverse
AB CD
Cib D1 1SQK 28   DQNFGELQSKLNEAV 14
MIM            2D1K 741 LKVGRRIANLMDEGQ 727
WIP D1         2A41        4 6 LKKGKSIDSLLANRG   32
WASP           2A3Z 444 LQIGQRIQDLLAGRG4 3 0
WAVE2          2A40 450 LQFGQRIASLLDSRA 436
C N
C N
Actin cleft
helix
Figure 5 Structure-based sequence alignment of G-actin-binding proteins engaging the subdomain 1–3 hydrophobic cleft. The alignment is
subdivided according to forward and reverse orientations of the actin-binding a-helix. Red boxes indicate experimentally observed helical
regions. Cleft-binding residues A, B, C and D are highlighted as well as the three actin ledge-binding residues. Residue numbering for gelsolin
and DBP are taken from the PDB coodinate ﬁles indicated and can be interconverted to full length sequence numbering by addition of 51 or 16
residues respectively.
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were normalised by subtracting the anisotropy at [LatB–actin]¼0
from all anisotropies for each peptide and multiplied by 1000.
Dissociation constants (Kd) were calculated by nonlinear regression
in GraFit version 5.0.13 (Erithacus Software) using the following
equation (Heyduk and Lee, 1990):
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where A is the measured value of anisotropy; Af and Ab are the
anisotropy values corresponding to free and bound peptide,
respectively; [Rt] and [Lt] are the total peptide (‘receptor’) and
total LatB–actin (‘ligand’) concentrations, respectively; Kd is the
dissociation constant. Kd values were derived from duplicate
samples in three independent experiments with s.e.m.
GST pull-down assays
Approximately 10
7 NIH3T3 ﬁbroblast cells on a 150-mm dish were
transfected with 6mg of pEF-FLAG-b-actin or its DF375 derivative
using Lipofectamine reagent (Invitrogen). Cells were maintained in
media containing 10% FCS for 1 day and serum-starved in media
containing 0.5% FCS for another day. Glutathione-sepharose 4B
(GE Healthcare) was saturated with recombinant GST (from empty
vector) or GST fusion peptides (RPEL1: residues 67–98; RPEL2:
111–142; RPEL3: 155–187; MAL(ﬂ) numbering) from Escherichia
coli (Rosetta(DE3) pLysS; Novagen) lysates, washed and used as
afﬁnity resin in a binding reaction with total NIH3T3 cell extract,
generated by lysis in binding buffer (50mM Tris–HCl pH 8.0,
100mM NaCl, 3mM MgCl2, 0.2mM EGTA, 0.2mM ATP, 1mM DTT
and protease inhibitors) through syringing and removal of insoluble
material by centrifugation. An equivalent of a conﬂuent 150-mm
dish of NIH3T3 cells was used for four binding reactions. Binding
was for 2h in binding buffer at 41C. The resin was washed three
times in binding buffer without protease inhibitors and subjected to
4–12% SDS–PAGE and western blotting with detection of the FLAG
epitope tag (M2 FLAG–HRP; Sigma) and total b-actin (AC-15;
Sigma). The blot was stained with Ponceau S to reveal bait input.
Immunoﬂuorescence microscopy
Immunoﬂuorescence microscopy was performed as described
earlier (Vartiainen et al, 2007; Guettler et al, 2008). NIH3T3 cells
(150000 cells per well in a six-well dish) were transfected with
100ng of C-terminally HA-tagged MAL (MAL-HA2) or the indicated
MAL-HA2 derivative. After transfection, cells were maintained in a
medium containing 0.5% FCS for 20h. Primary antibody was anti-
HA (12CA5; Roche). The localisation of each MAL derivative was
scored as predominantly nuclear, pancellular or predominantly
cytoplasmic in 100 cells.
Luciferase reporter assay
Luciferase reporter assays were performed as described earlier
(Vartiainen et al, 2007; Guettler et al, 2008). NIH3T3 cells (30000
cells per well in a 24-well dish) were transfected with SRF reporter
p3DA.luc (8ng), reference reporter ptk-RL (20ng) plus SRF-VP16
(40ng) or MAL (10ng) or MAL derivative (10ng). Where indicated,
C3 transferase was coexpressed (2ng). After transfection, cells were
maintained in a medium containing 0.5% FCS for 22h. Fireﬂy
luciferase activity was measured and normalised to Renilla
luciferase activity (Dual-Luciferase Reporter Assay System;
Promega).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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